MedTrace Logo

MAC Project, Monitoring of AntiCoagulant Therapies (MAC)

NCT04329390 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-05-07

No results posted yet for this study

Summary

MAC Project is a prospective cohort, multicenter, observational, no-profit study aimed to prospectively collect reliable real-life clinical information in unselected VTE or NVAF patients treated with any DOAC, during a medium-long term follow-up period.

Conditions

  • Anticoagulants and Bleeding Disorders

Interventions

DRUG

Anticoagulant drugs

Prescription of, or already on oral anticoagulant treatment.

Sponsors & Collaborators

  • Quovadis Associazione

    lead OTHER

Principal Investigators

  • Cristiano Bortoluzzi, MD · Quovadis Associazione

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2024-12-01
Completion
2024-12-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04329390 on ClinicalTrials.gov